News

Aquestive Therapeutics Announces FDA Acceptance Of New Drug Application And PDUFA Date For Anaphylmtm For The Treatment Of Severe Allergic Reactions
FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Aquestive Thera ...
Taiwan News6d
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
FDA assigns PDUFA target action date of January 31, 2026; WARREN, N.J., June (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Co ...
New York Magazine4d
Why Trump’s ‘TACO’ Nickname Has Him So Upset
Financial Times columnist Robert Armstrong coined the ... administration does not have a very high tolerance for market and economic pressure, and will be quick to back off when tariffs cause ...
MarketWatch3d
Synthomer PLC
Visit a quote page and your recently viewed tickers will be displayed here.
MarketWatch2d
BASF SE
Visit a quote page and your recently viewed tickers will be displayed here.
MarketWatch2d
Olectra Greentech Ltd.
Visit a quote page and your recently viewed tickers will be displayed here.
MarketWatch6d
Shin-Etsu Chemical Co. Ltd. ADR
Visit a quote page and your recently viewed tickers will be displayed here.